Global Monoclonal antibodies (mAbs) Biosimilars Market Report 2018 - Industry Analysis, Size, Share, production and Forecasts to 2025

 Buy Now

   Published Date : Aug-2018   |    Format : PDF   |    Pages : 90
This report studies the global market size of Monoclonal antibodies (mAbs) Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Monoclonal antibodies (mAbs) Biosimilars in these regions.
This research report categorizes the global Monoclonal antibodies (mAbs) Biosimilars market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of quality, efficacy and safety to an innovative reference medicinal product.
According to the report, one driver that will lead to the growth of this market is the rise in number of patent expiries.
In 2017, the global Monoclonal antibodies (mAbs) Biosimilars market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Monoclonal antibodies (mAbs) Biosimilars market based on company, product type, application and key regions.

The various contributors involved in the value chain of Monoclonal antibodies (mAbs) Biosimilars include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Monoclonal antibodies (mAbs) Biosimilars include
    Biocon
    Celltrion
    Dr. Reddy's Laboratories
    Hospira
    3SBio
    Accord Healthcare
    AET Biotech
    Allergan
    Amega Biotech
    Others

Market Size Split by Type
    Erythropoietin (EPO)
    Human Growth Hormone (HGH)
    Granulocyte- Colony Stimulating Factor (G-CSF)
    Monoclonal Antibody (mAb)
    Insulin
    Interferon (IFN)
    Others
Market Size Split by Application
    Anti-Cancer
    Anti-Inflammatory/Autoimmune

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Monoclonal antibodies (mAbs) Biosimilars market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Monoclonal antibodies (mAbs) Biosimilars market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Monoclonal antibodies (mAbs) Biosimilars manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Monoclonal antibodies (mAbs) Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Monoclonal antibodies (mAbs) Biosimilars submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Monoclonal antibodies (mAbs) Biosimilars are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Monoclonal antibodies (mAbs) Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Monoclonal antibodies (mAbs) Biosimilars Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type
        1.4.2 Erythropoietin (EPO)
        1.4.3 Human Growth Hormone (HGH)
        1.4.4 Granulocyte- Colony Stimulating Factor (G-CSF)
        1.4.5 Monoclonal Antibody (mAb)
        1.4.6 Insulin
        1.4.7 Interferon (IFN)
        1.4.8 Others
    1.5 Market by Application
        1.5.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Application
        1.5.2 Anti-Cancer
        1.5.3 Anti-Inflammatory/Autoimmune
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size
        2.1.1 Global Monoclonal antibodies (mAbs) Biosimilars Revenue 2016-2025
        2.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Sales 2016-2025
    2.2 Monoclonal antibodies (mAbs) Biosimilars Growth Rate by Regions
        2.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales by Regions
        2.2.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Monoclonal antibodies (mAbs) Biosimilars Sales by Manufacturers
        3.1.1 Monoclonal antibodies (mAbs) Biosimilars Sales by Manufacturers
        3.1.2 Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Manufacturers
        3.1.3 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio (CR5 and HHI)
    3.2 Monoclonal antibodies (mAbs) Biosimilars Revenue by Manufacturers
        3.2.1 Monoclonal antibodies (mAbs) Biosimilars Revenue by Manufacturers (2016-2018)
        3.2.2 Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Manufacturers (2016-2018)
    3.3 Monoclonal antibodies (mAbs) Biosimilars Price by Manufacturers
    3.4 Monoclonal antibodies (mAbs) Biosimilars Manufacturing Base Distribution, Product Types
        3.4.1 Monoclonal antibodies (mAbs) Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Monoclonal antibodies (mAbs) Biosimilars Product Category
        3.4.3 Date of International Manufacturers Enter into Monoclonal antibodies (mAbs) Biosimilars  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales by Type
    4.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Type
    4.3 Monoclonal antibodies (mAbs) Biosimilars Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Application

6 North America
    6.1 North America Monoclonal antibodies (mAbs) Biosimilars by Countries
        6.1.1 North America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
        6.1.2 North America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Monoclonal antibodies (mAbs) Biosimilars by Type
    6.3 North America Monoclonal antibodies (mAbs) Biosimilars by Application
    6.4 North America Monoclonal antibodies (mAbs) Biosimilars by Company

7 Europe
    7.1 Europe Monoclonal antibodies (mAbs) Biosimilars by Countries
        7.1.1 Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
        7.1.2 Europe Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Monoclonal antibodies (mAbs) Biosimilars by Type
    7.3 Europe Monoclonal antibodies (mAbs) Biosimilars by Application
    7.4 Europe Monoclonal antibodies (mAbs) Biosimilars by Company

8 Asia Pacific
    8.1 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars by Countries
        8.1.1 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
        8.1.2 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars by Type
    8.3 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars by Application
    8.4 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars by Company

9 Central & South America
    9.1 Central & South America Monoclonal antibodies (mAbs) Biosimilars by Countries
        9.1.1 Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
        9.1.2 Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Monoclonal antibodies (mAbs) Biosimilars by Type
    9.3 Central & South America Monoclonal antibodies (mAbs) Biosimilars by Application
    9.4 Central & South America Monoclonal antibodies (mAbs) Biosimilars by Company

10 Middle East and Africa
    10.1 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars by Countries
        10.1.1 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
        10.1.2 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars by Type
    10.3 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars by Application
    10.4 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars by Company

11 Company Profiles
    11.1 Biocon
        11.1.1 Biocon Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.1.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.1.5 Recent Development
    11.2 Celltrion
        11.2.1 Celltrion Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.2.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.2.5 Recent Development
    11.3 Dr. Reddy's Laboratories
        11.3.1 Dr. Reddy's Laboratories Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.3.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.3.5 Recent Development
    11.4 Hospira
        11.4.1 Hospira Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.4.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.4.5 Recent Development
    11.5 3SBio
        11.5.1 3SBio Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.5.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.5.5 Recent Development
    11.6 Accord Healthcare
        11.6.1 Accord Healthcare Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.6.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.6.5 Recent Development
    11.7 AET Biotech
        11.7.1 AET Biotech Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.7.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.7.5 Recent Development
    11.8 Allergan
        11.8.1 Allergan Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.8.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.8.5 Recent Development
    11.9 Amega Biotech
        11.9.1 Amega Biotech Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.9.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.9.5 Recent Development
    11.10 Others
        11.10.1 Others Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
        11.10.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
        11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Monoclonal antibodies (mAbs) Biosimilars Raw Material
        13.1.2 Monoclonal antibodies (mAbs) Biosimilars Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Monoclonal antibodies (mAbs) Biosimilars
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Production Market Share by Types (Product Category) in 2017
    Figure Erythropoietin (EPO) Product Picture
    Table Major Manufacturers of Erythropoietin (EPO)
    Figure Human Growth Hormone (HGH) Product Picture
    Table Major Manufacturers of Human Growth Hormone (HGH)
    Figure Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
    Table Major Manufacturers of Granulocyte- Colony Stimulating Factor (G-CSF)
    Figure Monoclonal Antibody (mAb) Product Picture
    Table Major Manufacturers of Monoclonal Antibody (mAb)
    Figure Insulin Product Picture
    Table Major Manufacturers of Insulin
    Figure Interferon (IFN) Product Picture
    Table Major Manufacturers of Interferon (IFN)
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Anti-Cancer
    Figure Anti-Inflammatory/Autoimmune
    Figure Monoclonal antibodies (mAbs) Biosimilars Report Years Considered
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size 2016-2025 (Million US$)
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales 2016-2025 (K Units)
    Table Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Regions 2016-2025 (K Units)
    Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Regions 2016-2025
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Regions 2016-2025
    Figure 2017 Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Regions
    Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Regions 2016-2025 (Million US$)
    Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions 2016-2025
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions
    Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Manufacturers (2016-2018) (K Units)
    Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Manufacturers (2016-2018)
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Manufacturers in 2017
    Table Monoclonal antibodies (mAbs) Biosimilars Revenue by Manufacturers (2016-2018) (Million US$)
    Table Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Manufacturers (2016-2018)
    Figure Monoclonal antibodies (mAbs) Biosimilars Value Share by Manufacturers in 2017
    Table Global Monoclonal antibodies (mAbs) Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Monoclonal antibodies (mAbs) Biosimilars Price (2016-2018) (USD/Unit)
    Table Monoclonal antibodies (mAbs) Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Monoclonal antibodies (mAbs) Biosimilars Product Category
    Table Date of International Manufacturers Enter into Monoclonal antibodies (mAbs) Biosimilars Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
    Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Type (2016-2025)
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type in 2017
    Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Type (2016-2025) (Million US$)
    Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Type (2016-2025)
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2016-2025)
    Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type in 2017
    Table Monoclonal antibodies (mAbs) Biosimilars Price by Type 2013-2018 (USD/Unit)
    Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
    Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Application (2016-2025)
    Figure Global Sales Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2025)
    Figure Global Sales Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2025)
    Figure North America Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
    Figure North America Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
    Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
    Table North America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
    Table North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
    Figure United States Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure United States Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
    Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
    Figure 2017 North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
    Table North America Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
    Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
    Figure 2017 North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
    Table North America Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
    Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
    Figure North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
    Figure Europe Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
    Figure Germany Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (K Units)
    Figure France Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure France Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure UK Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
    Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
    Figure Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
    Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
    Figure China Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure China Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure India Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
    Figure Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
    Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
    Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
    Figure Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
    Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
    Figure GCC Countries Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
    Table Biocon Company Details
    Table Biocon Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Biocon Recent Development
    Table Celltrion Company Details
    Table Celltrion Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Celltrion Recent Development
    Table Dr. Reddy's Laboratories Company Details
    Table Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Dr. Reddy's Laboratories Recent Development
    Table Hospira Company Details
    Table Hospira Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Hospira Recent Development
    Table 3SBio Company Details
    Table 3SBio Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table 3SBio Recent Development
    Table Accord Healthcare Company Details
    Table Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Accord Healthcare Recent Development
    Table AET Biotech Company Details
    Table AET Biotech Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table AET Biotech Recent Development
    Table Allergan Company Details
    Table Allergan Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Allergan Recent Development
    Table Amega Biotech Company Details
    Table Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Amega Biotech Recent Development
    Table Others Company Details
    Table Others Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Others Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Monoclonal antibodies (mAbs) Biosimilars Value Chain
    Table Typical Suppliers of Key Monoclonal antibodies (mAbs) Biosimilars Raw Material
    Table Monoclonal antibodies (mAbs) Biosimilars Customers List
    Table Monoclonal antibodies (mAbs) Biosimilars Sales Channels
    Table Monoclonal antibodies (mAbs) Biosimilars Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...